According to the Zhitong Finance App, Youzhiyou Bio-B (02496) announced its annual results for the year ended December 31, 2023. The group obtained additional revenue of RMB 13.014 million (RMB, same below) during the period, an increase of 408.36% over the previous year; shareholders' losses of 192 million yuan, an increase of 1.5% over the previous year; and a basic loss of 1.04 yuan per share.

According to the announcement, the Group's other revenue increased from 2.6 million yuan in the same period to 13 million yuan during the reporting period, mainly due to an increase of 9.7 million yuan in government subsidies, because the Group received subsidies from local governments, rewards for the Group's drug candidate development, and local government rewards for the Group's successful listing in September 2023.